Vitiligo and Its Aetiological Relationship to Organ-Specific Autoimmune Disease

Bor, Simon; Feiwel, M; Chanarin, I.

doi:10.1111/j.1365-2133.1969.tb15985.x

Cited by 102 publications

(43 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…APCAs were detected in vitiligo patients in rates ranging from 2.5 to 35.4% (table 4) [7,9,10,11,12,23,24,26,27,28,29,30,31,32,33]. We detected an APCA prevalence of 7.8% in our series consistent with the lower estimates from other studies.…”

Section: Discussionsupporting

confidence: 82%

See 1 more Smart Citation

Circulating Autoantibodies and Autoimmune Comorbidities in Vitiligo Patients: A Multicenter Italian Study

et al. 2014

View full text Add to dashboard Cite

Background: Autoimmune comorbidities and circulating autoantibodies have been observed in vitiligo patients, but differences in rate are present according to countries in which the studies were performed, perhaps owing to ethnic diversities or different trigger factors. Objective: To estimate the prevalence of circulating autoantibodies and overt autoimmune diseases in a fairly large sample of Italian vitiligo patients. Methods: 175 outpatients affected by vitiligo and referred to nine dermatological centers were included in the study. Patients were offered routine blood test, serological testing for thyroid function and search for autoantibodies. Results: At least one circulating autoantibody was detected in 61 (41.8%) of 146 subjects who underwent laboratory tests. Anti-thyroperoxidase (25.6%), anti-thyroglobulin (23.4%), antinuclear antibodies (16.8%) and anti-gastric parietal cell antibodies (7.8%) were the most noticed autoantibodies. 74 (41.5%) autoimmune comorbidities, mainly autoimmune thyroiditis (37%), were reported. Conclusion: The prevalence of autoimmune comorbidities and circulating autoantibodies in this study was in agreement with other surveys conducted on Caucasian patients.

show abstract

Section: Discussionsupporting

confidence: 82%

“…The clinical relevance of circulating APCAs in vitiligo patients is debated. Only about half of the papers including a control group showed statistical differences between vitiligo patients and controls (table 4) [7,9,10,12,26,27,29,30,33]. Anemia perniciosa has been described with a prevalence ranging from 2.7 to 8.7% [16,34].…”

Section: Discussionmentioning

confidence: 99%

Circulating Autoantibodies and Autoimmune Comorbidities in Vitiligo Patients: A Multicenter Italian Study

et al. 2014

View full text Add to dashboard Cite

show abstract

“…In the other case reported by Kim et al 6 , the patient was treated with PUVA for the vitiligo lesions and then the psoriasis developed strictly on the vitiligo lesions. From a review of the other literature, 22 of 821 Egyptian patients and 3 of 62 British patients with vitiligo also had psoriasis 7,8 . In Italy, there was an interesting retrospective study of 712 patients with vitiligo 9 .…”

Section: Discussionmentioning

confidence: 99%

A Case of Concurrent Vitiligo and Psoriasis

et al. 2009

View full text Add to dashboard Cite

Vitiligo and psoriasis are common dermatoses that occur in 1∼3% and 0.5% of the general population, respectively. There have been several reports of the concurrence of these diseases in the English medical literature. Yet the pathogenesis of the association between these two dermatoses is still unknown. Psoriasis may occur coincidentally with vitiligo and it may be strictly confined to the vitiliginous patches or it may occur elsewhere. Despite the reports in the English literature, there has been only one case of vitiligo and psoriasis coexisting in the same patient and these diseases occurred in separate sites in the Korean dermatologic literature. A 30-year-old man recently presented with spreading vitiligo on the right forearm and a 3-month history of guttate psoriasis on the left forearm. He had a family history of psoriasis without any history of associated autoimmune disease. Herein, we report on a case of coexisting vitiligo and psoriasis in the same individual at different sites and we review the relevant literature.

show abstract

“…Patients with vitiligo and psoriasis may have the koebner phenomenon [3]. In 1982, Koransky and Roenig described the association of vitiligo and psoriasis to be rare [6,7]. The increased incidence of presumably autoimmune diseases in patients with vitiligo and psoriasis is an evidence of the autoimmune origin of these two conditions [8].…”

Section: Introductionmentioning

confidence: 99%

Strict anatomical co existence and colocalization of vitiligo and psoriasis – a rare entity

Puri¹,

Puri²

2013

Our Dermatol Online

View full text Add to dashboard Cite

The coexistence of psoriasis and vitiligo is rare. We describe a case report of a 58 year old female patient who developed typical psoraiatic plaques covering completely or partly the vitiliginous areas of her skin. Her psoriasis was strictly limited to the vitiliginous patches with no involvement of the normal skin. Strict anatomical coexistence of both diseases is extremely rare and suggests a casual mechanism, possibly due to a koebner phenomenon but genetic and environmental factors may also be involved.

show abstract

Vitiligo and Its Aetiological Relationship to Organ-Specific Autoimmune Disease

Cited by 102 publications

References 20 publications

Circulating Autoantibodies and Autoimmune Comorbidities in Vitiligo Patients: A Multicenter Italian Study

Circulating Autoantibodies and Autoimmune Comorbidities in Vitiligo Patients: A Multicenter Italian Study

A Case of Concurrent Vitiligo and Psoriasis

Strict anatomical co existence and colocalization of vitiligo and psoriasis – a rare entity

Contact Info

Product

Resources

About